Fast Five Quiz: Rheumatoid Arthritis Management

Herbert S. Diamond, MD


June 10, 2020

A 2016 meta-analysis of 158 trials by Hazlewood and colleagues found that triple therapy with MTX, SSZ, and HCQ was more effective in preventing joint damage than MTX monotherapy. In contrast, no statistical difference in joint damage was found between patients treated with triple therapy versus those who received MTX coupled with a bDMARD or tsDMARD.

Learn more about combination therapies with csDMARDs.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.